Respiratory Device Market Outlook from 2024 to 2034

Respiratory Devices, in the light of combination therapies for the treatment of COPD and asthma, have made significant strides toward market growth. The recent COVID pandemic has also brought in front of healthcare professionals, the significance of respiratory devices as major tools for mitigating the spread and severity of respiratory illnesses. This is set to take the market valuation to an astounding USD 26873.7 million in 2024.

Medicare advancements, thanks to the hefty investments by private as well as public healthcare companies have also amplified the acceptance and adoption of these devices in the developed and developing parts of the world. As the industry analysis exhibits an outstanding growth of 9.90% CAGR through 2034, the future prospects of the respiratory device market seem very lucrative.

Manufacturers involved in the production and distribution of these devices are also curating equipment that is not only effective but also affordable to the general populace. Despite the advent of alternative methodologies and treatments, the market valuation is very likely to surpass USD 69,072.5 million by the end of 2034. Medical inclusion policies and initiatives by governments in underdeveloped and developing countries are also bringing an enormous number of people under the purview of the respiratory device market.

Attributes Details
Market Value for 2024 USD 26,873.7 million
Projected Market Value for 2034 USD 69,072.5 million
Value-based CAGR of the Market for 2024 to 2034 9.90%

Category-wise Insights

Positive Airway Pressure Devices Retain their Dominance in the Healthcare Sector

Various types of respiratory devices have flooded the market, thanks to the advent of numerous companies in the market. Home oxygen concentrators, portable oxygen devices, positive airway pressure devices, etc., are some of the prominent ones. Among these, positive airway pressure devices are estimated to hold a market share of 31.30% in 2024.

Attributes Details
Product Positive Airway Pressure Devices
Market Share (2024) 31.30%
  • The demand for positive airway pressure devices in the healthcare sector is touching the skies as they offer effective treatment for sleep apnea and other respiratory disorders. These devices are also inexpensive ways to improve quality of life and reduce the risk of complications associated with respiratory diseases.
  • Positive airway pressure devices also offer significant benefits in reducing daytime fatigue. This feature of it has increased its popularity among the daily office-goers and frequent travelers who struggle with sleep disturbances.

Hospitals Consume Almost Half Respiratory Devices

Respiratory devices find their applications in a wide spectrum of healthcare facilities such as hospitals, ambulatory surgical centers, clinics, long-term care centers, etc. Hospitals to take the largest share of 40.70% of the overall market in 2024.

Attributes Details
End User Hospitals
Market Share (2024) 40.70%
  • The clamor for respiratory equipment in the hospitals is touching the skies, especially post-pandemic, as they are vital for treating patients with severe respiratory complications such as pneumonia, acute respiratory distress syndrome (ARDS), and chronic obstructive pulmonary disease (COPD).
  • Hospitals are also generating substantial demand for respiratory equipment as they offer proper airway management and ventilation during surgical procedures.

Country-wise Insights

Countries CAGR (2024 to 2034)
Germany 12.10%
France 11.90%
India 11.40%
Canada 10.30%
Mexico 10.10%

Mergers and Acquisitions to Shape the Future of Germany’s Respiratory Device Market

The market in Germany is a promising one. It is slated to surge at a CAGR of 12.10% through 2034.

  • Responding to the growing demand for sophisticated, modern, and AI-driven connected respiratory devices, companies involved in the manufacturing of respiratory aids are partnering up with software companies.
  • Partnerships and acquisitions are common in the country as they give both companies opportunities to take advantage of each other’s expertise. For instance, in June 2022, ResMed finalized the acquisition of Medifox Dan, a German out-of-hospital software firm. The deal, focused on respiratory devices, bolstered ResMed's capabilities in providing tools for staffing plans and care documentation to healthcare providers.

Sophisticated Medical Infrastructure Supports the Adoption of Respiratory Aids in France

France is also one of the most lucrative countries in this market. It is very likely to rise at a CAGR of 11.90%.

  • When it comes to a well-established healthcare sector, France is considered one of the most advanced countries, not just in Europe but all over the world. Each year, millions of patients flock to the nation to take advantage of its advanced medical facilities.
  • This creates a conducive environment for healthcare facilities such as hospitals, ambulatory surgical centers, clinics, etc., to accept and adopt these respiratory equipment for the treatment process of various diseases associated with lung functions.

Government Initiatives to Benefit India’s Respiratory Device Market

The future of the market in India also looks very bright. The market is slated to progress at a CAGR of 11.40% through 2034.

  • The Indian government in the last few years has announced a multitude of schemes and policies to medically include a substantial portion of its population in the country’s healthcare sector. This has increased the need for respiratory devices in the country as hospitals are increasingly adopting these devices.
  • The country’s overall improvement in the healthcare infrastructure, especially after the pandemic, has also made it easier for healthcare facilities to acquire and install respiratory devices, thus amplifying the market prospects in the country.

Made-in-Canada Devices to Help Elderly Patients Breathe

Canada’s respiratory device market is slated to inflate at a CAGR of 10.30% from 2024 to 2034.

  • Canada has always been a frontrunner in medical advancements, thanks to the industry-academia collaboration in the country. The presence of world-class medical institutes in the country has led to the development of suave respiratory aids in Canada.
  • In March 2021, St. Clair College collaborated with Windsor-based researchers to develop the Canada Hood, a ventilation device aiding critically ill patients. Built by Crest Mold Technology Inc., it aimed to address respiratory challenges during the COVID-19 pandemic.

Mexico’s Respiratory Device Market to Profit amidst Rising Smog

The respiratory aid market in Mexico is also very likely to flourish in the coming years. It is slated to inflate at a CAGR of 10.10% through 2034.

  • Mexico is known for its agricultural activities. However, people’s tendency to burn waste after the harvest generates a substantial amount of smog in the environment. This has amplified the adoption of respiratory devices in the country.

Competitive Landscape

The market, globally, is a well-established one with a multitude of companies vying for international dominance. Hospitals, ambulatory surgical centers, clinics, etc., heavily rely on these companies for their respiratory requirements. These companies are also pouring billions of dollars into the development of product offerings that are not only effective but also affordable for the general populace.

Recent Developments

  • In February 2024, ResMed launched its AirCurve 11 series, featuring bilevel-positive airway pressure devices in the USA The devices utilized inspiratory and expiratory positive airway pressure, aiding sleep apnea treatment with improved comfort and compliance.
  • In August 2023, researchers from the University of Canterbury developed BOB, a tool unlocking respiratory data from devices. It facilitated data-driven respiratory care, reducing costs and wait times for patients. The software, developed by UC Engineering PhD students, provided real-time data interpretation and report generation for GPs.
  • In February 2024, Dräger was honored with Frost & Sullivan's Company of the Year Award in global respiratory care, recognizing its innovative solutions and customer impact. The award highlighted Dräger's commitment to excellence in medical technologies and services.
  • In February 2024, University Medical Devices secured USD 1.6 million in seed funding to launch MicroWash, a groundbreaking nasal specimen collection device. The investment aimed to advance infrastructure and bring the device to market, addressing respiratory infections with a more comfortable alternative to nasal swabs.
  • In April 2024, Clario announced its acquisition of AI-powered software company ArtiQ, bolstering its Respiratory Solutions portfolio. The integration of ArtiQ's technology with Clario's devices enhanced data quality and patient experience in respiratory clinical trials.
  • In June 2023, SunMed acquired Avanos Medical's respiratory health business for USD 110 million. The deal included inventory, assets, and leases for manufacturing facilities in Mexico. This expanded SunMed's portfolio after purchasing Vyaire Medical's hardware earlier that year.
  • In July 2023, ResMed acquired Somnoware, a software maker specializing in sleep and respiratory diagnostics. This strategic move bolstered ResMed's position in the market, particularly amidst competitor challenges.
  • In October 2022, Australia-based firm AirPhysio launched respiratory devices in Chennai, India. Brett Lee, former Australian cricketer, unveiled the AirPhysio and Better Breathing product range alongside Apollo Hospital’s managing director Suneeta Reddy. The company partnered with Medsmart and Apollo Group for the rollout.

Key Companies

  • Massimo Corporation
  • Teleflex Incorporated
  • Fisher & Paykel Healthcare Limited
  • ResMed Inc.
  • Hamilton Medical AG
  • Medtronic plc.
  • Koninklijke Philips N.V.
  • Smith’s Medical
  • General Electric Healthcare Limited
  • Drägerwerk AG & Co. KGaA
  • Inogen Inc.

Key Coverage in the Respiratory Device Market

  • Demand Analysis of Respiratory Devices For COPD
  • Overview of Airway Devices in Anesthesia
  • Market Insights on Breathing Aids
  • Industrial Analysis of Breathing Aids for Sleep Apnea
  • Emerging Trends in the Respiratory Device Market

Key Segments of the Respiratory Device Industry

By Product Categories:

  • Respiratory Consumables
    • Respiratory Masks
    • Nasal Cannulas
    • Oxygen Tubing Sets
    • Breathing Filters
  • Nebulizers
    • Compressed Jet Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Concentrators
    • Home Oxygen Concentrators
    • Portable Oxygen Concentrators
    • Positive Airway Pressure (PAP) Devices
    • Polysomnography Devices
    • Ambulatory PSG Devices
    • Clinical PSG Devices
    • Pulse Oximeters
    • Mechanical Ventilators
    • Spirometers

By End Users:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Long Term Care Centers
  • Others

By Regions:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • Middle East & Africa (MEA)

Table of Content

  • 1. Executive Summary
  • 2. Market Overview
  • 3. Market Background
  • 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034
  • 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product
    • 5.1. Respiratory Consumables
      • 5.1.1. Respiratory Mask
      • 5.1.2. Nasal Cannulas
      • 5.1.3. Oxygen Tubing Sets
      • 5.1.4. Breathing Filters
    • 5.2. Oxygen Concentrators
      • 5.2.1. Home Oxygen Concentrators
      • 5.2.2. Portable Oxygen
      • 5.2.3. Concentrators`
      • 5.2.4. Positive Airway Pressure (PAP) Devices
      • 5.2.5. Polysomnography Devices
      • 5.2.6. Ambulatory PSG Devices
      • 5.2.7. Clinical PSG Devices
      • 5.2.8. Pulse Oximeters
      • 5.2.9. Mechanical Ventilators
      • 5.2.10. Spirometers
    • 5.3. Nebulizers
      • 5.3.1. Compressed Jet Nebulizers
      • 5.3.2. Ultrasonic Nebulizers
  • 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Users
    • 6.1. Hospitals
    • 6.2. Ambulatory Surgical Centers
    • 6.3. Clinics
    • 6.4. Long Term Care Centers
    • 6.5. Others
  • 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
    • 7.1. North America
    • 7.2. Latin America
    • 7.3. Western Europe
    • 7.4. Eastern Europe
    • 7.5. South Asia and Pacific
    • 7.6. East Asia
    • 7.7. Middle East and Africa
  • 8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country
  • 15. Key Countries Market Analysis
  • 16. Market Structure Analysis
  • 17. Competition Analysis
    • 17.1. Massimo Corporation
    • 17.2. Teleflex Incorporated
    • 17.3. Fisher & Paykel Healthcare Limited
    • 17.4. ResMed Inc.
    • 17.5. Hamilton Medical AG
    • 17.6. Medtronic plc.
    • 17.7. Koninklijke Philips N.V.
    • 17.8. Smith’s Medical
    • 17.9. General Electric Healthcare Limited
    • 17.10. Drägerwerk AG & Co. KGaA
    • 17.11. Inogen Inc.
  • 18. Assumptions & Acronyms Used
  • 19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034

Table 5: Global Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 6: Global Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 7: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 8: North America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 9: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 10: North America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 11: North America Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 12: North America Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 13: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 14: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 15: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 16: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 17: Latin America Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 18: Latin America Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 19: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 20: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 21: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 22: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 23: Western Europe Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 24: Western Europe Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 25: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 26: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 27: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 28: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 29: Eastern Europe Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 30: Eastern Europe Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 31: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 32: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034

Table 33: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 34: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034

Table 35: South Asia and Pacific Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 36: South Asia and Pacific Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 37: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 38: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034

Table 39: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 40: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034

Table 41: East Asia Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 42: East Asia Market Volume (Units) Forecast by End Users, 2019 to 2034

Table 43: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034

Table 44: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034

Table 45: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034

Table 46: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034

Table 47: Middle East and Africa Market Value (US$ Million) Forecast by End Users, 2019 to 2034

Table 48: Middle East and Africa Market Volume (Units) Forecast by End Users, 2019 to 2034

List of Figures

Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034

Figure 2: Global Market Value (US$ Million) by End Users, 2024 to 2034

Figure 3: Global Market Value (US$ Million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Volume (Units) Analysis by Region, 2019 to 2034

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 8: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 9: Global Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 12: Global Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 13: Global Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 14: Global Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 15: Global Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 16: Global Market Attractiveness by Product, 2024 to 2034

Figure 17: Global Market Attractiveness by End Users, 2024 to 2034

Figure 18: Global Market Attractiveness by Region, 2024 to 2034

Figure 19: North America Market Value (US$ Million) by Product, 2024 to 2034

Figure 20: North America Market Value (US$ Million) by End Users, 2024 to 2034

Figure 21: North America Market Value (US$ Million) by Country, 2024 to 2034

Figure 22: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 23: North America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 26: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 27: North America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 28: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 29: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 30: North America Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 31: North America Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 32: North America Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 34: North America Market Attractiveness by Product, 2024 to 2034

Figure 35: North America Market Attractiveness by End Users, 2024 to 2034

Figure 36: North America Market Attractiveness by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ Million) by Product, 2024 to 2034

Figure 38: Latin America Market Value (US$ Million) by End Users, 2024 to 2034

Figure 39: Latin America Market Value (US$ Million) by Country, 2024 to 2034

Figure 40: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 41: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 44: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 45: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 48: Latin America Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 49: Latin America Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 50: Latin America Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 51: Latin America Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 52: Latin America Market Attractiveness by Product, 2024 to 2034

Figure 53: Latin America Market Attractiveness by End Users, 2024 to 2034

Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 55: Western Europe Market Value (US$ Million) by Product, 2024 to 2034

Figure 56: Western Europe Market Value (US$ Million) by End Users, 2024 to 2034

Figure 57: Western Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 58: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 59: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 62: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 63: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 66: Western Europe Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 67: Western Europe Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 68: Western Europe Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 70: Western Europe Market Attractiveness by Product, 2024 to 2034

Figure 71: Western Europe Market Attractiveness by End Users, 2024 to 2034

Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 73: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034

Figure 74: Eastern Europe Market Value (US$ Million) by End Users, 2024 to 2034

Figure 75: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034

Figure 76: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 77: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 80: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 81: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 84: Eastern Europe Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 85: Eastern Europe Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 88: Eastern Europe Market Attractiveness by Product, 2024 to 2034

Figure 89: Eastern Europe Market Attractiveness by End Users, 2024 to 2034

Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 91: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034

Figure 92: South Asia and Pacific Market Value (US$ Million) by End Users, 2024 to 2034

Figure 93: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034

Figure 94: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 95: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 98: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 99: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 102: South Asia and Pacific Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 103: South Asia and Pacific Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 106: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034

Figure 107: South Asia and Pacific Market Attractiveness by End Users, 2024 to 2034

Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 109: East Asia Market Value (US$ Million) by Product, 2024 to 2034

Figure 110: East Asia Market Value (US$ Million) by End Users, 2024 to 2034

Figure 111: East Asia Market Value (US$ Million) by Country, 2024 to 2034

Figure 112: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 113: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 116: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 117: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 118: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 120: East Asia Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 121: East Asia Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 122: East Asia Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 123: East Asia Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 124: East Asia Market Attractiveness by Product, 2024 to 2034

Figure 125: East Asia Market Attractiveness by End Users, 2024 to 2034

Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 127: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034

Figure 128: Middle East and Africa Market Value (US$ Million) by End Users, 2024 to 2034

Figure 129: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034

Figure 130: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034

Figure 131: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 134: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034

Figure 135: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 138: Middle East and Africa Market Value (US$ Million) Analysis by End Users, 2019 to 2034

Figure 139: Middle East and Africa Market Volume (Units) Analysis by End Users, 2019 to 2034

Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by End Users, 2024 to 2034

Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by End Users, 2024 to 2034

Figure 142: Middle East and Africa Market Attractiveness by Product, 2024 to 2034

Figure 143: Middle East and Africa Market Attractiveness by End Users, 2024 to 2034

Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

Frequently Asked Questions

How much is the Respiratory Device Market Currently Worth?

The market is expected to be worth USD 26,873.7 million in 2024.

What is the Sales Forecast for Respiratory Devices through 2034?

The respiratory device market is expected to reach USD 69,072.5 million by 2034.

At What Rate is the Respiratory Device Market growing?

The market is set to develop at a CAGR of 9.90% from 2024 to 2034.

Which are the key Companies in the Market?

Massimo Corporation, Teleflex Incorporated, Fisher & Paykel Healthcare Limited, ResMed Inc., Hamilton Medical AG, Medtronic plc, and Koninklijke Philips N.V., are some of the major players in the market.

What was the overall Value of the Respiratory Device Market in 2023?

The market valuation in 2023 was USD 24,623 million.

Explore Therapeutic Device Insights

Future Market Insights

Respiratory Device Market